Healthcare products are distinct in the context of COVID-19 (coronavirus) because demand for certain goods, namely personal protective equipment (PPE), is rapidly rising while factory closures are limiting production. Manufacturers in active facilities are ramping up production to attempt to meet growing global demand, but downstream buyers are still dealing with shortages. ProcurementIQ's Coronavirus Risk Assessment for Healthcare Products will help you understand the immediate risks and how to mitigate them.
Learn more about:
- Industry Risk Analysis
- Supply Chain Risk Analysis - including Key Suppliers, Vendors and Key Buyers
- Mitigating Supply Chain Risk with Best Practices, plus Related Market News
- Company-Wide Best Practices and Day-to-Day Best Practices